Reply
Ben L. Da, Christopher Koh, Theo Heller – 18 September 2019
Letter to the Editor: Portal Pressure in Non‐Cirrhotic Portal Hypertension: To Measure or Not to Measure
Ashish Kumar, Praveen Sharma, Anil Arora – 18 September 2019
Hepatocyte ELOVL Fatty Acid Elongase 6 Determines Ceramide Acyl‐Chain Length and Hepatic Insulin Sensitivity in Mice
Takashi Matsuzaka, Motoko Kuba, Saori Koyasu, Yuta Yamamoto, Kaori Motomura, Sundaram Arulmozhiraja, Hiroshi Ohno, Rahul Sharma, Takuya Shimura, Yuka Okajima, Song‐iee Han, Yuichi Aita, Yuhei Mizunoe, Yoshinori Osaki, Hitoshi Iwasaki, Shigeru Yatoh, Hiroaki Suzuki, Hirohito Sone, Yoshinori Takeuchi, Naoya Yahagi, Takafumi Miyamoto, Motohiro Sekiya, Yoshimi Nakagawa, Masatsugu Ema, Satoru Takahashi, Hiroaki Tokiwa, Hitoshi Shimano – 17 September 2019
Hepatic IRF2BP2 Mitigates Nonalcoholic Fatty Liver Disease by Directly Repressing the Transcription of ATF3
Jing Fang, Yan‐Xiao Ji, Peng Zhang, Lin Cheng, Yue Chen, Jun Chen, Yanfang Su, Xu Cheng, Yan Zhang, Tianyu Li, Xuehai Zhu, Xiao‐Jing Zhang, Xiang Wei – 17 September 2019
Immunomodulatory Mechanism of Acyclic Nucleoside Phosphates in Treatment of Hepatitis B Virus Infection
Kazumoto Murata, Senko Tsukuda, Futoshi Suizu, Akihiro Kimura, Masaya Sugiyama, Koichi Watashi, Masayuki Noguchi, Masashi Mizokami – 17 September 2019
γδ T Cells Promote Steatohepatitis by Orchestrating Innate and Adaptive Immune Programming
Alejandro Torres‐Hernandez, Wei Wang, Yuri Nikiforov, Karla Tejada, Luisana Torres, Aleksandr Kalabin, Salma Adam, Jingjing Wu, Lu Lu, Ruonan Chen, Aaron Lemmer, Jimmy Camargo, Mautin Hundeyin, Brian Diskin, Berk Aykut, Emma Kurz, Juan A. Kochen Rossi, Mohammed Khan, Miguel Liria, Gustavo Sanchez, Nan Wu, Wenyu Su, Steven Adams, Muhammad Israr Ul Haq, Mohammad Saad Farooq, Varshini Vasudevaraja, Joshua Leinwand, George Miller – 17 September 2019
Hypoxia‐Inducible Factor‐2α Reprograms Liver Macrophages to Protect Against Acute Liver Injury Through the Production of Interleukin‐6
Rachel Y. Gao, Meng Wang, Qihui Liu, Dechun Feng, Yankai Wen, Yang Xia, Sean P. Colgan, Holger K. Eltzschig, Cynthia Ju – 17 September 2019
Reply
Kristopher P. Croome, C. Burcin Taner – 17 September 2019
Integration of an Addiction Team in a Liver Transplantation Center
Hélène Donnadieu‐Rigole, Laura Jaubert, José Ursic‐Bedoya, Bertrand Hanslik, Thibault Mura, Lucie Gamon, Stéphanie Faure, Francis Navarro, Pascal Perney, Astrid Herrero, Georges‐Philippe Pageaux – 16 September 2019 – Up to 50% of liver transplantation (LT) recipients with known or clandestine alcohol‐use disorder (AUD) before surgery return to alcohol use after LT. However, only severe alcohol relapse, which varies in frequency from 11% to 26% of patients, has an impact on longterm survival and significantly decreases survival rates after 10 years.
MELD‐GRAIL‐Na: Glomerular Filtration Rate and Mortality on Liver‐Transplant Waiting List
Sumeet K. Asrani, Linda W. Jennings, W.R. Kim, Patrick S. Kamath, Josh Levitsky, Mitra K. Nadim, Giuliano Testa, Michael D. Leise, James F. Trotter, Goran Klintmalm – 16 September 2019